Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Update

Bavarian Nordic A/S (OTCMKTS:BVNRY) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 8,600 shares, a growth of 109.8% from the December 31st total of 4,100 shares. Based on an average daily trading volume, of 27,900 shares, the short-interest ratio is currently 0.3 days.

Bavarian Nordic A/S Stock Performance

Shares of OTCMKTS BVNRY traded up $0.32 during mid-day trading on Thursday, reaching $9.28. The company had a trading volume of 2,922 shares, compared to its average volume of 8,088. The stock’s 50 day moving average is $9.01 and its 200-day moving average is $10.13. Bavarian Nordic A/S has a twelve month low of $6.86 and a twelve month high of $14.60. The stock has a market capitalization of $2.19 billion, a PE ratio of 13.45 and a beta of 1.65.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.